Barley β-glucan accelerates wound healing by favoring migration versus proliferation of human dermal fibroblasts.


Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
15 Apr 2019
Historique:
received: 10 10 2018
revised: 23 01 2019
accepted: 25 01 2019
entrez: 9 2 2019
pubmed: 9 2 2019
medline: 21 5 2019
Statut: ppublish

Résumé

β-Glucans are considered candidates for the medication in different human pathologies. In this work, we have purified β-glucan from a selected barley line and tested their effects in primary human dermal fibroblasts. Unexpectedly, we have observed that this compound promoted a short-transitory proliferation arrest at 24 h after its addition on the medium. We have determined that this transitory arrest was dependent on the cell-cycle regulator protein Retinoblastoma. Moreover, dermal fibroblasts increase their migration capacities at 24 h after barley β-glucan addition. Also, we have described that barley β-glucan strongly reduced the ability of fibroblasts to attach and to spread on cell plates. Our data indicates that barley β-glucan signal induces an early response in HDF cells favoring migration versus proliferation. This feature is consistent with our observation that the topical addition of our barley β-glucan in vivo accelerates the wound closure in mouse skin.

Identifiants

pubmed: 30732776
pii: S0144-8617(19)30103-1
doi: 10.1016/j.carbpol.2019.01.090
pii:
doi:

Substances chimiques

beta-Glucans 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

389-398

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

N P Fusté (NP)

Departament de Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida and Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Catalonia, Spain.

M Guasch (M)

Departament de Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida and Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Catalonia, Spain.

P Guillen (P)

Departament de Química, ETSEA, Universitat de Lleida and Agrotecnio, Lleida, Spain.

C Anerillas (C)

Departament de Medicina Experimental, Universitat de Lleida and Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain.

T Cemeli (T)

Departament de Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida and Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Catalonia, Spain.

N Pedraza (N)

Departament de Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida and Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Catalonia, Spain.

F Ferrezuelo (F)

Departament de Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida and Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Catalonia, Spain.

M Encinas (M)

Departament de Medicina Experimental, Universitat de Lleida and Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain.

M Moralejo (M)

Departament de Química, ETSEA, Universitat de Lleida and Agrotecnio, Lleida, Spain. Electronic address: mmv@quimica.udl.cat.

E Garí (E)

Departament de Ciències Mèdiques Bàsiques, Facultat de Medicina, Universitat de Lleida and Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Catalonia, Spain. Electronic address: eloi.gari@cmb.udl.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH